IRCT20190619043948N1CompletedPhase 2
Kidney-protective Effect of Magnesium Supplementation in Carboplatin-containing Chemotherapy for Pediatric Cancer
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 2 years to 16 years (—)
- Sex
- All
Inclusion Criteria
- •Children over 2 years of age with malignancy receiving Carboplatin
Exclusion Criteria
- •Kidney disorder with GFR under 30
- •Receiving other platinum drugs or other nephrotoxic drugs
- •Receiving antibiotics
Investigators
Similar Trials
Recruiting
Not Applicable
Kidney protective effect of magnesium supplementation on cisplatin-containing chemotherapy in pediatric cancer: a randomized controlled,phase 2 studypediatric oncologyJPRN-UMIN000029215Tokyo Metropolitan Children's Medical center80
Completed
Phase 2
Effect of magnesium supplementation on improvement of patients with diabetic nephropathyDiabetes.Diabetic nephropathyIRCT201404271485N12Isfahan University of medical sciences80
Completed
Phase 2
The effect of Magnesium in migraine prophylaxisMigraineIRCT2013010411995N1Vice chancellor for research Ahvaz University of Medical Sciences110
Recruiting
Not Applicable
Renoprotective effects of potassium supplementation in chronic kidney diseaseChronic kidney diseaseNL-OMON53024Erasmus MC, Universitair Medisch Centrum Rotterdam532
Recruiting
Phase 3
Magnesium in depression and anxiety and sleep qualityOther functional disturbances following cardiac surgery.I97.1IRCT20200523047556N1Bagheiat-allah University of Medical Sciences30